medac
Medac GmbH (stylized as medac) is a German, worldwide operating pharmaceutical company based in Wedel near Hamburg and Tornesch, which is privately owned.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Arsenic trioxide medac | Arsenic trioxide | 2020-09-17 | ||
| Capecitabine medac | Capecitabine | 2012-11-19 | ||
| Imatinib medac | Imatinib | 2013-09-25 | ||
| Leflunomide medac | Leflunomide | 2010-07-27 | ||
| Pemetrexed medac | Pemetrexed | 2015-11-26 | 2035 | |
| Spectrila | Asparaginase | 2016-01-14 | ||
| Temomedac | Temozolomide | 2010-01-25 | ||
| Trecondi | Treosulfan | 2019-06-20 | ||
| Zoledronic acid medac | Zoledronic acid | 2012-08-03 | 2023-2028 | |
| Carmustine medac (previously carmustine obvius) | Carmustine | 2018-07-18 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use